Stock Code: 000028/200028 Notice No.: 2022-36
Short Form of the Stock: SinopharmAccord /Accord B
China NationalAccord Medicines Corporation Ltd.
Summary of Semi-Annual Report 2022
I. Important Notice
The summary of semi-annual report is excerpted from the full text of the semi-annual report. For the details, investors should
carefully read the full text of the semi-annual report published on Juchao Information website (www.cninfo.com.cn) and Shenzhen
Stock Exchange Website etc., appointed by CSRC.
All directors are attended the Board Meeting for report deliberation.
Prompt of modified auditing opinion
□Applicable √ Not applicable
Profit distribution pre-plan of common stock or capitalizing of common reserves pre-plan deliberated by the Board in the reporting
period
□Applicable √ Not applicable
The Company plans not to carry out cash dividend and bonus distribution and capitalizing of common reserves
Profit distribution pre-plan of preferred stock deliberated and approved by the Board in the reporting period
□Applicable √ Not applicable
II. Basic information of the company
1. Company profile
Short form of the stock SinopharmAccord, Accord B Stock code 000028, 200028
Stock exchange for listing Shenzhen Stock Exchange
Person/Way to contact Secretary of the Board Rep. of security affairs
Name Chen Changbing Wang Zhaoyu
Accord Pharm. Bldg., No. 15, Ba Gua Si Accord Pharm. Bldg., No. 15, Ba Gua Si
Office add. Road, Futian District, Shenzhen, Guangdong Road, Futian District, Shenzhen, Guangdong
Province Province
Tel. +(86)755 25875222 +(86)755 25875222
E-mail gyyzinvestor@sinopharm.com gyyz0028@sinopharm.com
2. Main financial data and index
Whether it has retroactive adjustment or re-statement on previous accounting data
□ Yes √ No
Increase/decrease in this
Current Period Same period of last year
report y-o-y
Operating revenue (RMB) 36,128,910,049.98 33,163,091,887.39 8.94%
Net profit attributable to shareholders of 674,215,912.93 741,445,013.25 -9.07%
the listed Company (RMB)
Net profit attributable to shareholders of
the listed Company after deducting non- 652,857,302.76 720,954,408.22 -9.45%
recurring gains and losses (RMB)
Net cash flow arising from operating 1,041,664,059.17 1,229,373,283.57 -15.27%
activities (RMB)
Basic earnings per share (RMB/Share) 1.57 1.73 -9.25%
(note 1)
Diluted earnings per share (RMB/Share) 1.57 1.73 -9.25%
Weighted average ROE 4.44% 5.22% 0.78percentage points down
Increase/decrease in this
End of current period End of last period report-end over that of last
period-end (+,-)
Total assets (RMB) 45,968,980,824.57 42,783,682,431.81 7.45%
Net assets attributable to shareholder of
15,342,295,205.24 14,924,938,052.50 2.80%
listed Company (RMB)
3. Number of shareholders and share-holding
Unit: share
Total preference shareholders
Total common shareholders at with voting rights recovered at
43,689 0
period-end end of reporting period (if
applicable)
Top ten shareholders
Information of shares
Full name of Nature of Proportion of Amount of pledged, tagged or frozen
Shareholders shareholder shares held shares held Amount of restricted shares held
查看PDF原文
